Browse user-created protocols Real protocols from the community that include Glow Blend Glow Blend Research References It is a preclinical compound Glow Blend Glow Blend is a preclinical compound Dose range 250-500mcg daily shows wound healing and anti-inflammatory properties n.d
NNMT is highly expressed in fat tissue, which has made its inhibition a focus of metabolic research
Common research protocols use 1-3 mg daily via subcutaneous injection
GHRP-6 is known for causing intense, uncontrollable hunger and can raise cortisol and prolactin levels, whereas Ipamorelin provides the same growth hormone benefits without the hunger or hormonal spikes
Cagrilintide is the most evidence-anchored option because CagriSema shows that adding amylin to a GLP-1 backbone improves outcomes
Additionally, low blood sugar levels, or hypoglycemia, can cause symptoms such as dizziness, weakness, and nausea alongside hunger